News

Partner companies' news

KemPharm, Inc. Announces Top-Line Results from Clinical Trial Evaluating the Safety and Pharmacokinetics of “Higher-Dose SDX”
CELEBRATION, Fla., Dec. 14, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and ...
Acorn Management Partners, Administrator
— December 2021 — 474 views KMPH

KemPharm Named 2021 David J. Gury Company of the Year by BioFlorida
CELEBRATION, Fla., Dec. 13, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and ...
Acorn Management Partners, Administrator
— December 2021 — 516 views KMPH

Anixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant
SAN JOSE, Calif. and STUTTGART, Germany, Dec. 7, 2021 /PRNewswire/ --  Anixa Biosciences, Inc. [1]  (NASDAQ: ANIX), a biotechnology company focused...
Acorn Management Partners, Administrator
— December 2021 — 467 views ANIX

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives